Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin
- PMID: 9696474
- DOI: 10.1016/s0304-3959(98)00043-8
Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin
Abstract
Gabapentin (GP) has been shown to have antihyperalgesic properties and the site of drug action is reported to be the central nervous system. The goal of the present study was to determine whether GP also has a peripheral site of action. Rats received intraplantar 20-microl injections of 6, 60 or 600 microg GP + 2% formalin, 300 or 600 microg S-(+)-3-isobutylgaba + 2% formalin, 600 microg R-(-)-3-isobutylgaba + 2% formalin or formalin alone. The two lower doses of GP significantly reduced flinching and lifting/licking behavior during phase 2; however, phase 1 behaviors were unaffected, 600 microg GP significantly reduced these nociceptive behaviors during both phases. 600 microg S-(+)-3-isobutylgaba also reduced formalin-induced nociceptive behaviors; however, 600 microg of the isomer R-(-)-3-isobutylgaba had no effect. The antihyperalgesic effect of GP (1) was not due to a systemic effect since animals injected with 600 microg GP in one hindpaw and 2% formalin into the contralateral hindpaw developed nociceptive behaviors which were no different than those seen in animals injected with formalin alone; (2) was not due to a local anesthetic effect since needle sticks within the drug-injected region evoked paw withdrawal behavior which was not different from pre-drug levels; (3) was blocked by 20 microl D-serine but not by L-serine. Although the mechanism of action of GP has yet to be elucidated, these results indicate that GP has a peripheral site of action and thus may offer a novel therapeutic agent for topical or local treatment of pain of peripheral origin.
Similar articles
-
Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.Br J Pharmacol. 1997 Aug;121(8):1513-22. doi: 10.1038/sj.bjp.0701320. Br J Pharmacol. 1997. PMID: 9283683 Free PMC article.
-
The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration.Anesth Analg. 2002 Apr;94(4):975-80, table of contents. doi: 10.1097/00000539-200204000-00037. Anesth Analg. 2002. PMID: 11916807
-
Characteristic of interactions between intrathecal gabapentin and either clonidine or neostigmine in the formalin test.Anesth Analg. 2004 May;98(5):1374-9, table of contents. doi: 10.1213/01.ane.0000107937.00902.fc. Anesth Analg. 2004. PMID: 15105218
-
Gabapentin in the treatment of neuropathic pain.Palliat Med. 2004 Jan;18(1):5-11. doi: 10.1191/0269216304pm845ra. Palliat Med. 2004. PMID: 14982201 Review.
-
Targeted topical peripheral analgesics in the management of pain.Curr Pain Headache Rep. 2003 Feb;7(1):34-8. doi: 10.1007/s11916-003-0007-3. Curr Pain Headache Rep. 2003. PMID: 12525268 Review.
Cited by
-
Comparison of the effects of preoperative celecoxib and gabapentin on pain, functional recovery, and quality of life after total knee arthroplasty: A randomized controlled clinical trial.J Res Med Sci. 2023 Jun 12;28:50. doi: 10.4103/jrms.jrms_416_22. eCollection 2023. J Res Med Sci. 2023. PMID: 37496639 Free PMC article.
-
Potentiation of Morphine-Induced Antinociception by Propranolol: The Involvement of Dopamine and GABA Systems.Front Pharmacol. 2017 Nov 10;8:794. doi: 10.3389/fphar.2017.00794. eCollection 2017. Front Pharmacol. 2017. PMID: 29209205 Free PMC article.
-
Preclinical Comparison of Mechanistically Different Antiseizure, Antinociceptive, and/or Antidepressant Drugs in a Battery of Rodent Models of Nociceptive and Neuropathic Pain.Neurochem Res. 2017 Jul;42(7):1995-2010. doi: 10.1007/s11064-017-2286-9. Epub 2017 May 15. Neurochem Res. 2017. PMID: 28508174
-
Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.Psychopharmacology (Berl). 2017 Jun;234(11):1781-1794. doi: 10.1007/s00213-017-4583-z. Epub 2017 Mar 22. Psychopharmacology (Berl). 2017. PMID: 28332005
-
A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin.Naunyn Schmiedebergs Arch Pharmacol. 2015 Nov;388(11):1129-40. doi: 10.1007/s00210-015-1145-y. Epub 2015 Jul 3. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 26134846 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical